Is Compass Pathways Plc (CMPS) overvalued? · $305.0M cap
Compass Pathways Plc (CMPS) is a medical care facilities company listed on US.
This page asks whether Compass Pathways Plc (CMPS) looks expensive on cached numbers — not a short thesis.
No cached income statement for CMPS, so there is no earnings base to call rich or cheap.
CMPS currently screens at market cap $305.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CMPS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CMPS stock page for the full model, not this heading.
Not investment advice.